HHS: FDA COVID-19 emergency use authorizations remain in effect
Health and Human Services Secretary Xavier Becerra this week amended the February 2020 COVID-19 emergency use authorization declaration so that the Food and Drug Administration’s emergency use authorizations for COVID-19 diagnostics, personal protective equipment, other medical devices, and drug and biological products will remain in effect until there is no longer a “significant potential” for a COVID-19 public health emergency or the authorized devices or products have been approved. For more information, see the FDA’s EUA questions and answers.
Related News Articles
Headline
The Food and Drug Administration Nov. 9 cleared for marketing the Flowflex COVID-19 Antigen Home Test, the first COVID-19 antigen test and second COVID-19 at-…
Headline
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
The National Institute for Occupational Safety and Health this week revoked eight N95 filtering facepiece respirator approvals and four powered air-…
Headline
In response to questions from AHA and others and informed by testing results, the Food and Drug Administration April 21 announced that health care…
Headline
Health care providers and consumers should not use certain N95 respirators made by O&M Halyard because they do not meet quality and performance…
Headline
The National Institute for Occupational Safety and Health recently rescinded all respirator approvals issued to Pacific PPE Corp. at the company’s request,…